Trial Profile
Efficacy of voglibose added to alogliptin in Japanese patients with diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Voglibose (Primary) ; Alogliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Oct 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Apr 2013 Planned number of patients changed from 60 to 180 as reported by University Hospital Medical Information Network - Japan.
- 22 Jan 2013 New trial record